S4-E14.2 - NICE and FibroScan for Primary Care: Utilizing Early Detection to Prevent Cirrhosis

Send us Fan MailThis week on Surfing the NASH Tsunami, we are offering a co-host ‘roundtable’ catch-up between Jörn Schattenberg, Louise Campbell and Roger Green. This is a fun, casual conversation that looks into first quarter highlights and a preview of what’s to come in quarter two of 2023.In this conversation, each Surfer picks one thing that's anticipated to happen in the second quarter that they think is likely to be most momentous or compelling. Louise leads with comments around the rigorous approval process of NICE for primary care access to FibroScan in the UK. While extensive, these protocols produce world-leading cost-benefit analysis. The group goes on to discuss how different systems contribute to progress in the field through different qualities. Louise asserts that facilitating frontline screening will enable early detection and ultimately help prevent cirrhosis for many patients. As the conversation winds down, Jörn offers notes on the upcoming EASL Congress and Roger shares his latest metaphor to describe the dynamism of fighting fatty liver disease. If you enjoy the episode, have questions or interest around its contents and Fatty Liver disease, we kindly ask that you submit reviews wherever you download our discussions. Alternatively, you can write to us directly at [email protected] Safe and Surf On!